UK Approves Moderna's Omicron-Containing Covid-19 Booster Vaccine [MarketWatch]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: MarketWatch
shot, ahead of a planned fall vaccination campaign to shore up immune defenses against the virus. The so-called bivalent vaccine is directed against both the original strain of SARS-CoV-2, the virus that causes Covid-19, and the first Omicron variant, also known as BA.1, which drove large waves of infection over the winter. Britain's Medicines and Healthcare products Regulatory Agency on Monday said the approval was based on clinical trial data showing that a booster with the bivalent Moderna vaccine triggered a strong immune response against both Omicron BA.1 and the original strain. It said exploratory analysis found that the bivalent vaccine also generated a good immune response against Omicron subvariants BA.4 and BA.5 that are driving waves of infection in some parts of the world. "What this bivalent vaccine gives us is a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve," said June Raine, chief executive of the MHRA, in a
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign [Yahoo! Finance]Yahoo! Finance
- Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination CampaignAccesswire
- Covid vaccine makers to clash in London over mRNA patent dispute [FT.com - Mergermarket]FT.com - Mergermarket
- Covid vaccine makers to clash in London over mRNA patent dispute [Financial Times (FT.com) (UK)]Financial Times
- As deadline nears, global pandemic treaty talks hobbled by delays and quarrels [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 4/19/24 - Form 4
- 4/17/24 - Form 144
- 4/16/24 - Form 4
- MRNA's page on the SEC website